(Q44296986)

1 December 2017

Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate (English)

1 reference

1 December 2017

cutaneous leishmaniasis

1 reference

1 reference

Faghihi G

1

1 reference

PubMed ID

12558620

1 December 2017

Tavakoli-kia R

series ordinal

2

1 reference

1 December 2017

1 January 2003

1 reference

Clinical and Experimental Dermatology

1 December 2017

1 reference

1 December 2017

28

1 reference

1 December 2017

1

1 reference

1 December 2017

13-16

1 reference

Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years

1 December 2017

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2003.01169.X

Cutaneous leishmaniasis: clinical aspect

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2003.01169.X

Treatment of cutaneous leishmaniasis with antimony: intramuscular versus intralesional administration

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2003.01169.X

10.1046/J.1365-2230.2003.01169.X

21 January 2018

Identifiers

DOI

1 reference

release_q46gpq2lmjhkrb25i67gz3wgz4

1 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/q46gpq2lmjhkrb25i67gz3wgz4

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

12558620

1 reference

PubMed ID

12558620